You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞生物科技(01548.HK):C輪非境內投資者共同持有9928.6萬股Probio Cayman C類優先股
格隆匯 02-10 20:18

格隆匯2月10日丨金斯瑞生物科技(01548.HK)公佈,於2023年1月17日,Probio Cayman與C輪投資者(包括公司)訂立認購協議,據此,Probio Cayman同意於交割時發行及出售而C輪投資者同意購買合共3.2億股C類優先股,總代價約2.24億美元。作為Probio CaymanC輪融資的一部分,於初步交割時,Probio Cayman也將同時向公司發行及出售4285.7萬股C類優先股,總代價約3000萬美元。

認購協議中初步交割的所有條件均已達成或獲豁免,初步交割於2023年2月10日發生。緊隨初步交割後,C輪非境內投資者(包括公司)共同持有9928.6萬股Probio Cayman C類優先股,總代價約6,950萬美元。於本公吿日期,僅發生初步交割。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account